Stockscreener 앱 받기
5.17
6.16%
0.30
시간 외 거래:
5.17
Foghorn Therapeutics Inc 주식(FHTX)의 최신 뉴스
Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update - ADVFN Brasil
Foghorn Therapeutics Inc. stock outlook for YEARWeekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
How sentiment analysis helps forecast Foghorn Therapeutics Inc.2025 Market Outlook & Daily Volume Surge Trade Alerts - Newser
Foghorn Therapeutics’ SWOT analysis: innovative cancer therapy stock faces pivotal trials - Investing.com
Foghorn Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Drop Watch & Intraday High Probability Alerts - Newser
Using flow based indicators on Foghorn Therapeutics Inc.July 2025 Summary & Community Verified Swing Trade Signals - Newser
Is Foghorn Therapeutics Inc. stock ready for a breakout2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Sentiment analysis tools applied to Foghorn Therapeutics Inc.Treasury Yields & AI Powered Trade Plan Recommendations - Newser
How to escape a deep drawdown in Foghorn Therapeutics Inc.Recession Risk & Community Consensus Picks - Newser
Applying Wyckoff theory to Foghorn Therapeutics Inc. stockTrend Confirmation Scanner with Entry Focus - Newser
How Foghorn Therapeutics Inc. stock performs during market volatility - Newser
Leading vs lagging indicators on Foghorn Therapeutics Inc. performanceQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - Newser
Automated trading signals detected on Foghorn Therapeutics Inc.Smart Entry Signals for Active Traders - Newser
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Understanding Foghorn Therapeutics Inc.’s price movementAI Powered Buy Point Forecast Planner - Newser
How cyclical is Foghorn Therapeutics Inc.’s revenue streamFast Growth Mid Cap Picks - sisain.net
Using data filters to optimize entry into Foghorn Therapeutics Inc.Daily Upside Movement Prediction With Data - Newser
Using portfolio simulators with Foghorn Therapeutics Inc. includedGrowth Watchlist for Long Term Positioning - Newser
Comparing Foghorn Therapeutics Inc. in custom built stock radarsShort-Term Swing Opportunity Summary Sheet - Newser
Is Foghorn Therapeutics Inc. meeting your algorithmic filter criteriaAI Model Forecasting Reversal and Breakout Zones - Newser
Can technical indicators confirm Foghorn Therapeutics Inc.’s reversalStock Market Watch with Smart Filters - Newser
Research Analysts Offer Predictions for FHTX Q3 Earnings - Defense World
Will Foghorn Therapeutics Inc. bounce back from current supportAI Driven Swing Trade Forecasting Insight - Newser
Real time alert setup for Foghorn Therapeutics Inc. performanceShort-Term Bounce Forecast for Oversold Stocks - Newser
Top Risks to Consider Before Buying Foghorn Therapeutics Inc. StockChart Scanner for Swing Trade Timing - Newser
What high frequency data says about Foghorn Therapeutics Inc.Free Entry Alert With Low Drawdown Strategy - Newser
Can volume confirm reversal in Foghorn Therapeutics Inc.Value Holding Return Summary With Outlook - Newser
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing - Yahoo Finance
Wedbush Research Analysts Boost Earnings Estimates for FHTX - Defense World
How to recover losses in Foghorn Therapeutics Inc. stockSafe Entry Screening with Data Backed Analysis - Newser
Foghorn Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayHigh Conviction Stock Long-Term Summary - Newser
Is Foghorn Therapeutics Inc. trending in predictive chart modelsFree Community Strategy With High Win Rate - Newser
Q1 Earnings Estimate for FHTX Issued By Wedbush - Defense World
1.67%
자본화:
|
볼륨(24시간):